Innoviva
INVA
#5502
Rank
NZ$2.68 B
Marketcap
NZ$37.20
Share price
1.26%
Change (1 day)
24.75%
Change (1 year)

Earnings for Innoviva (INVA)

Earnings in 2026 (TTM): NZ$0.72 Billion

According to Innoviva's latest financial reports the company's current earnings are NZ$0.43 Billion. In 2025 the company made an earning of NZ$0.58 Billion, an increase over its 2024 earnings that were of NZ$66.55 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Innoviva from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.72 B24.21%
2025 NZ$0.58 B774.24%
2024 NZ$66.55 M-80.74%
2023 NZ$0.34 B-32.36%
2022 NZ$0.51 B-35.56%
2021 NZ$0.79 B25.7%
2020 NZ$0.63 B52.11%
2019 NZ$0.41 B10.77%
2018 NZ$0.37 B56.59%
2017 NZ$0.23 B125.53%
2016 NZ$0.10 B-417.36%
2015 -NZ$33.4 Million-74.49%
2014 -NZ$0.14 Billion-25.19%
2013 -NZ$0.18 Billion430.06%
2012 -NZ$33.01 Million-83.92%
2011 -NZ$0.21 Billion39.82%
2010 -NZ$0.15 Billion2.84%
2009 -NZ$0.15 Billion-8.62%
2008 -NZ$0.16 Billion-47.92%
2007 -NZ$0.31 Billion-5.92%
2006 -NZ$0.32 Billion19.8%
2005 -NZ$0.27 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.15 Billion-119.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$32.32 Million-104.33%๐Ÿ‡บ๐Ÿ‡ธ USA